UK Covid infections increasing by at least 3% per day

UK Health Security Agency say R rate is now estimated to be between 1.2 and 1.5

Infections are growing by between 3 to 6 per cent per day, new data released by the UK Health Security Agency (UKHSA) show. EPA.

The UK Health Security Agency has published new figures for the growth rate of coronavirus in England.

These are the first estimates since December 23 and include the R rate, or the virus's reproduction number.

The growth rate for infections is estimated to be between 3 and 6 per cent per day. The previous estimate was between 0 and 3 per cent.

Meanwhile, the R is estimated to be between 1.2 and 1.5, meaning every 10 people will infect between 12 and 15 people. The previous estimate was between 1 and 1.2.

But although these figures have only recently been published, because of the time it takes to assess how the virus is spreading, the numbers are merely a report on what was happening two or three weeks ago, the UKHSA says.

The report comes as health authorities on Friday reported the deaths of 229 people within 28 days of testing positive for Covid-19 as well as 178,250 lab-confirmed Covid-19 cases, the third straight day of decline.

A total of 179,756 cases and 231 deaths were reported on Thursday.

Separate figures published by the Office for National Statistics show there have now been 174,000 deaths registered in the UK where Covid-19 was mentioned on the death certificate.

A total of 18,454 people were in hospital in the UK with Covid-19 as of January 6, government figures show.

• 

  A member of staff walks through a ward for Covid-19 patients at King's College Hospital in London. PA

• 

  A sign urging residents to wear face masks in Nottingham. People who have tested positive for the coronavirus will now be able to leave home on day seven if they have two negative tests. AP

• 

  A waiter cleans a table at an empty restaurant in London. Authorities are still urging people to stay at home amid fears over the Omicron coronavirus variant. Reuters

• 

  Passengers wearing Santa hats sit on the top deck of a tour bus as they view the Christmas lights in central London. AFP

• 

  Nurses work at a desk surrounded by Christmas decorations in a ward for Covid-19 patients at King's College Hospital. PA

• 

  Empty tables outside a restaurant in the Seven Dials district of London. Covid-19 infections have surged in recent days, authorities say. AFP

• 

  People receive a dose of a Covid-19 vaccine at a temporary clinic set up in the Titanic Exhibition Centre in Belfast. AFP

• 

  Shoppers stroll through Carnaby Street in London. AP

• 

  People, most of them without masks, skate around the Christmas tree at the Natural History Museum in London. Reuters

• 

  Health workers speak with a patient inside a vaccination centre in Liverpool. AFP

• 

  Tourists cross Westminster Bridge in London. AP

• 

  A sign outside the Natural History Museum in South Kensington, London, which has been forced to close its doors for a week due to staff shortages related to coronavirus. PA

• 

  Commuters at a quiet Waterloo Station in south London. PA

The UKHSA also released additional data on Friday revealing that booster shots are continuing to provide high levels of protection against severe disease from the Omicron coronavirus variant among older adults.

About three months after receiving a third shot, protection against hospital admission among those aged 65 and over remained at about 90 per cent, the UKHSA said.

“The data is highly encouraging and emphasises the value of a booster jab,” said Wei Shen Lim, chairman of Covid-19 immunisation on the government's Joint Committee on Vaccination and Immunisation.

“The current data show the booster dose is continuing to provide high levels of protection against severe disease, even for the most vulnerable older age groups,” he said.

He added that the findings show there is no current need for people to have a fourth shot, he added, but that this will continue to be reviewed.

Protection against mild symptomatic infection was more short lived than against severe disease and dropped to about 30 per cent after the three-month mark, the UKHSA said.